Genetic Technologies Settles Litigation with Roche 454 | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has reached a settlement with Roche 454 Life Sciences over alleged infringement of Genetic Technologies' primary non-coding DNA patent.

The Australian firm said that it has reached a settlement, covenant, and license agreement with 454, which also covers its affiliates within Roche. The terms of the agreement are confidential.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.